Globus Medical
GMED
489 hedge funds and large institutions have $6.65B invested in Globus Medical in 2025 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 170 increasing their positions, 179 reducing their positions, and 64 closing their positions.
818% more call options, than puts
Call options by funds: $19.1M | Put options by funds: $2.08M
25% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 64
2% more funds holding
Funds holding: 480 → 489 (+9)
1.61% more ownership
Funds ownership: 84.23% → 85.84% (+1.6%)
1% less capital invested
Capital invested by funds: $6.73B → $6.65B (-$73M)
5% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 179
20% less funds holding in top 10
Funds holding in top 10: 15 → 12 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$110M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$68.3M |
| 3 |
AP
Antipodes Partners
Royal Exchange,
Australia
|
+$51.2M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$48.5M |
| 5 |
MAP
Madison Avenue Partners
New York
|
+$48.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$90.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$63.5M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$62.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$41M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$37.7M |
GMED Hedge Fund Activity: Q3 2025 in Review
489 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2025, worth a combined $6.65B — down 1.1% from $6.73B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new GMED positions and 64 closed out — a net gain of 16 holders — while 170 added to existing stakes and 179 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $110M. The largest seller was Axa, exiting entirely with an estimated $90.2M sold.
- 489 institutional investors held Globus Medical (GMED) as of Q3 2025, up from 480 in Q2 2025.
- Funds reported $6.65B of Globus Medical stock for Q3 2025, down 1.1% quarter-over-quarter.
- 80 funds opened new Globus Medical positions in Q3 2025 and 64 closed out, a net change of +16 holders.
- The largest Globus Medical buyer in Q3 2025 was AllianceBernstein, an estimated $110M added.
- The largest Globus Medical seller in Q3 2025 was Axa, an estimated $90.2M sold.
Based on aggregated 13F filings for Q3 2025.